241.96 0.00 (0.00%)
After hours: 5:27PM EST
|Bid||241.90 x 1000|
|Ask||242.21 x 1100|
|Day's Range||238.78 - 243.68|
|52 Week Range||224.43 - 368.83|
|Beta (3Y Monthly)||1.14|
|PE Ratio (TTM)||20.50|
|Earnings Date||Dec 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||285.00|
Which names qualify as potential Warren Buffett stocks? See this screen feauturing companies like Alibaba, Mastercard, Alphabet, Veeva and more.
Just two weeks before Thanksgiving, the first two retailers are opening at the Lower Heights District, a 24-acre project near the Heights and the Washington Corridor.
Wedgewood Partners, a St. Louis, Missouri-based investment firm, has released its 2019 Q3 investor letter – you can download a copy here. The investment firm reported mixed results for the quarter, with composite returns largely flat at 0.39% for the quarter. Meanwhile, the benchmark Russell 1000 Growth Index and the S&P 500 Index gained 1.49% and 1.87%, respectively. Wedgewood Partners wrote extensively […]
Instinet initiated a number of retailers on Friday, calling AutoZone Inc. (price target $162), Walmart Inc. (price target $132) and Lowe's Cos. (target price $132) its best ideas. "Our positive outlook is based on share gains in stores and online, particularly in grocery," Instinet wrote about Walmart. "We also believe Walmart is well positioned to take advantage of a favorable consumer backdrop, but can also outperform in a weaker environment due to defensive characteristics." On the other hand, analysts started Ulta Beauty Inc. at reduce with a $215 price target. "We believe that growth will remain slow industrywide for the near term, which, even with Ulta's share gains, will lead to below-trend comps, a tougher margin outlook, and potential earning misses." In off-price, buy-rated TJX Cos. (price target $65) is preferred over Burlington Stores Inc. (price target $220). Analysts rate Ross Stores Inc. neutral with $110 price target. The SPDR S&P Retail ETF is up 8.3% for the year to date while the S&P 500 index and the Dow Jones Industrial Average are up 23% and 18.3% respectively for the period.
All stocks correct. It's also a fact that growth stocks come and go. But sometimes Wall Street's cautious dismissal of future prospects can lead to big-time profits. And right now Abiomed (NASDAQ:ABMD), Ulta Beauty Salon (NASDAQ:ULTA) and Baidu (ADR) (NASDAQ:BIDU) are three former dearly-held companies that maintain growth stock potential and bottoms ready for purchase.ABMD, ULTA and BIDU stock owners have all enjoyed better years than 2019. Shares of Abiomed are off roughly 33%. Ulta Salon has a blemish of 5% for its year-to-date performance. And Baidu is down by about 22% for the calendar year. But it's not the end of the road for these once dearly held growth stocks.The truth is most companies won't become the next Apple (NASDAQ:AAPL), Netflix (NASDAQ:NFLX) or Home Depot (NYSE:HD). But Wall Street also has a great record of overcompensating when the narrative turns to doom and gloom in growth stocks.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Medical Marijuana Stocks to Cure Your Portfolio I believe common but large corrections aided by Wall Street's willingness to flee the scene when there's a bump or two in the road are now setting up new opportunities for ABMD, ULTA and BIDU stock in 2020 and beyond. Let's examine what's happening in this diverse trio of former growth stocks who've endured big-time corrections and whose stories are poised for new chapters of growth off and on the price chart. Growth Stocks to Buy: Abiomed (ABMD)Abiomed is the first of our stocks to buy. The medical device maker and former staple within growth names pitched at Investor's Business Daily recently delivered a mixed, but decent and very well-received earnings report. And the story gets better for today's bullish investors. Away from the headlines, analysts are still projecting a five-year growth rate of 24% for the cardiac specialist. At the same time, with Wall Street having literally written off ABMD with a sizable correction in 2019, a bottom has now emerged on the price chart.ABMD Stock Strategy: With a confirmed monthly chart candlestick reversal pattern off its 10-year cycle, 62% retracement level and oversold stochastics crossover set-up turning higher, ABMD is a stock to buy today. I'd recommend setting a stop-loss beneath $190, which allows enough leeway off and on the price chart. To reduce exposure on a rally, a 50% retracement within the right side of a new bullish base in the range of $300 - $320 makes sense. Ulta (ULTA)Ulta Beauty is another former growth superstar hit by an inevitable correction made worse by failing to live up to Wall Street's overly high expectations. But don't think for a second the brick-and-mortar beauty retailer isn't still a growth stock or at least one well-positioned as a stock to buy.Sporting an estimated growth rate of over 10% for the next five years, a forward price multiple of 18 and share price that successfully tested its 10-year 38% Fibonacci level and five-year trendline support last month, ULTA has the right foundation as a stock to buy. * 7 Large-Cap Stocks to Give a Wide Berth ULTA Stock Strategy: My recommendation in this growth stock is to wait for a second price confirmation of the September high of $251.76. Also, the September pivot low of $224.66 is our line in the sand. The fact is, shares have backtracked and, while stochastics are oversold, the indicator hasn't yet put together a bullish crossover confirmation. Baidu (BIDU)Baidu is the last of our growth stocks to buy. The China-based search giant and diversified technology play touted as China's Alphabet (NASDAQ:GOOGL, (NASDAQ:GOOG) has lost roughly two-thirds of its value since mid-2018. Blame it on dashed expectations and even some scandal along the way. And you can.But as the dust has settled on shares, BIDU stock is showing sure signs of a comeback worth buying into. This week, the company reported stronger-than-expected results and Wall Street has been receptive to the report. To be clear, growth of days past isn't there at this point, but the stage for a turnaround in this market leader is certainly in progress.BIDU Stock Strategy: Technically, the reaction to Baidu's earnings has hoisted shares of this return-to-growth stock above a failed bear flag and three-month long consolidation just below its decade-plus 62% level. With stochastics backing a longer-term bottom, BIDU is a stock to buy. However, given a shorter-term overbought condition and expectations this turnaround will take some time to unfold, I'd recommend watching for an opportunity to buy Baidu on weakness, rather than momentum. Also, consider a stop-loss below $100.Disclosure: Investment accounts under Christopher Tyler's management do not currently own positions in securities mentioned in this article. The information offered is based upon Christopher Tyler's observations and strictly intended for educational purposes only; the use of which is the responsibility of the individual. For additional market insights and related musings, follow Chris on Twitter @Options_CAT and StockTwits. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Sell Before They Roll Over * 5 Beaten-Up Stocks to Buy That Could Be Saved By An Acquisition * 4 Startup Stocks Getting Smashed The post 3 Former Growth Stocks to Consider Buying Again appeared first on InvestorPlace.
Elf Beauty earnings easily topped fiscal Q2 views while the bargain cosmetics maker's sales rose. Shares broke out, but then erased gains.
(Bloomberg Opinion) -- A $70 billion buyout of Walgreens Boots Alliance Inc. would be straight out of the Stefano Pessina playbook. While the circumstances behind the informal talks between the company and private equity firms, including KKR & Co, are unknown, as the chief executive and largest shareholder of the drugstore chain, Pessina was probably at the forefront. Any deal would be impossible without the backing of the Italian billionaire who owns 16% of the group.Pessina has spent more than four decades building his pharmaceutical distribution and retail empire through swashbuckling deals. He has been patient, adding to the group piece by piece. But he’s also been opportunistic. With shares in Walgreens down by about 24% over the past year, he may have spotted his chance to extract the group from the public markets.Indeed, he’s been here before. In 2006, Pessina merged his company Alliance UniChem with Boots. A year later he took the combined group private — with KKR — in a $16 billion deal, Europe’s biggest buyout at the time.Acquiring Walgreens would dwarf Alliance Boots. It would probably need several financial sponsors and substantial debt funding. Walgreen’s leverage is already fairly high. Net debt will be about 1.8 times Ebitda at the end of the current financial year, according to Bloomberg analyst estimates.The retail business generates cash. Even so, this might not be the best time to gear up. The Alliance Boots buyout saddled the group with about $12 billion of debt, just as the global economy was hit by the financial crisis. With concerns about a U.S. recession escalating, there’s a risk of history repeating itself.What’s more, the retail landscape has shifted dramatically over the past decade. Amazon.com Inc. is a much more muscular force than it was in 2007 and seems to targeting the pharmaceutical business. Meanwhile, Walgreens faces other rivals such as Ulta Beauty Inc. in the U.S. and A.S. Watson Group, which owns Britain’s Superdrug.To keep up, the privately owned company would need to invest, as well as service its debt.Walgreens also has a huge number of stores, which may need to be pruned. While it might be easier to close shops away from the glare of the public markets, terminating leases is expensive.Pessina — and more importantly any private equity backers — will need an exit eventually should the buyout succeed. Last time he was able to persuade Walgreens to purchase Alliance Boots. There’s no such obvious contender now. The group could relist on the public market, but potential holders would have to be convinced that the investment case was different this time around.After conquering the U.S. Pessina has long had China in his sights, and has already made several investments there. It’s possible that he wants to tie up with an Asian operator to create his ultimate goal: a truly global pharmaceutical distribution and retail group. Given the trade tensions between the U.S. and China that might not be so easy right now. But things might look better after five years — a typical private equity holding period.At 78, some other executives are heading for the beach. But Pessina has shown no signs of slowing down. In fact, another mega buyout may just be the next step in his global ambitions.\--With assistance from Chris Hughes.To contact the author of this story: Andrea Felsted at email@example.comTo contact the editor responsible for this story: James Boxell at firstname.lastname@example.orgThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Andrea Felsted is a Bloomberg Opinion columnist covering the consumer and retail industries. She previously worked at the Financial Times.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
Estée Lauder (EL) stock fell even after strong earnings results for the first quarter of fiscal 2020. Now analysts are cutting price targets for the stock.
One of the hardest things to do in the stock market is to time the bottom in a falling stock. That's because momentum is a very real thing. Stocks that have been trending higher, usually continue to trend higher. Stocks that have been trending lower, usually continue to trend lower.But that doesn't mean investors should completely avoid buying the dip in falling stocks. Those can often turn into some of the most profitable trades.Instead, it means investors should be very selective in buying dips and pay attention to the clues surrounding these falling stocks.InvestorPlace - Stock Market News, Stock Advice & Trading TipsOne such clue is insider activity. That is, investors should look for falling stocks which insiders are buying on the dip, since this show of confidence from insiders is usually a bullish sign that the worst is over and a bottom is close. * 7 Stocks to Buy in November With that in mind, let's take a look at five cheap and falling stocks that insiders are buying the dip in, and see whether or not these stocks have actually bottomed. Insider Buying Stocks: Ulta (ULTA)Source: Jonathan Weiss / Shutterstock.com Shares of cosmetics retailer Ulta (NASDAQ:ULTA) fell off a cliff in late August after the company reported ugly second-quarter numbers which missed revenue and profit estimates, and also included a cut to its full-year profit guide.In the wake of that big selloff, insiders have turned bullish. Specifically, there have been five open market purchases of ULTA stock since the post-earnings selloff, led by long-time board member Charles Heilbronn. This was the guy was cashing out on ULTA stock on the way up -- before the plunge. Thus, the fact that he's buying the dip now is a bullish reversal sign.Indeed, Heilbronn is part of a broader reversal here. Over the past three months, there have been zero insider sales of ULTA stock. Compare that to the prior nine months, where there were 37 insider sale transactions. In other words, insiders aren't selling anymore.Does that mean the worst is over for ULTA stock? I think so. The post-Q2 selloff was overdone. Sure, the numbers weren't great, and the growth narrative here is slowing. But, this is a still a very strong company, supported by secular cosmetics adoption tailwinds, healthy margins, direct retail expansion and a big unit growth runway.In the long run, those strong growth drivers will power profits significantly higher. As those profits trend higher, so will ULTA stock. The Tile Shop (TTS)Source: Rosemarie Mosteller / Shutterstock.com Struggling retailer The Tile Shop (NASDAQ:TTS) recently reported really ugly third-quarter numbers in late October that included negative comparable-store sales growth, margin erosion, a net loss and a surprise delisting announcement. In response to the ugly print, TTS stock lost more than two-thirds of its value.In the wake of the huge selloff, though, insiders stepped up. Board member Peter Jacullo bought roughly 2.4 million shares over the span of a few days, while the chief financial officer and chief accounting officer both acquired about 60,000 shares. In response to this vote of confidence from insiders, investors have bought the dip, too. From its post-earnings lows, TTS stock is already up 90% -- and it's only been a few days.Will this rebound last? It's tough to say. At current levels TTS stock is certainly cheap. But, revenues, margins and profits are all dropping. Current fundamentals imply that they will keep dropping, as The Tile Shop finds itself as an undifferentiated retailer in a crowded building materials space that is rapidly consolidating around leaders like Home Depot (NYSE:HD) and Floor & Decor (NYSE:FND). * 7 Dividend Stocks That Could Struggle to Continue Payout Hikes As such, this insider-driven rebound in TTS stock may just be a head-fake. Until the fundamentals turn around here, caution is warranted. Stage Stores (SSI)Source: WhisperToMe via Wikimedia CommonsDepressed department store operator Stage Stores (NYSE:SSI) has been the recipient of significant insider buying over the past three months as the company has more aggressively pursued its discount-oriented turnaround plan.Here's the story. Stage Stores owns two types of stores -- full-price stores and off-price stores. The full-price stores aren't doing well. The off-price stores are doing much better. But, most of the company's stores today are full-price stores. Management wants to change that. They want to close some of those full-price stores and turn the rest into off-price stores. Thus, the big plan here is to turn Stage Stores into a mini TJX (NYSE:TJX) or Ross Stores (NASDAQ:ROST).Will it work? It could. And, if it does, SSI stock could turn into a multi-bagger in the long run. Just look at the sales multiple on SSI. It's below 0.05. Now look at the sales multiples on TJX and ROST. They are each north of 1.8.Insiders clearly believe in the plan. Over the past three months, as the company has converted multiple full-price stores into off-price ones, there have been 10 open market insider purchases, and just one insider sale.Should you buy in too? That depends on your risk appetite. The stock has come very far, very fast, so if the turnaround plan doesn't work as hoped, the stock could fall a lot from here. At the same time, there's also a bunch of upside potential in the event the turnaround does work. It's a typical high-risk, high-reward situation -- and it's tough to say which way the stock will go next. GameStop (GME)Source: Emil O / Shutterstock.com Shares of struggling video game retailer GameStop (NYSE:GME) have been in a secular decline for several years now, as revenues and profits have been wiped out by a shift from physical to digital video games.But, GME stock has essentially doubled since mid-August amid renewed optimism regarding the company's growth prospects in 2020 and 2021. Specifically, at the end of 2020, PlayStation and Xbox are set to unveil new generation video game consoles for the first time since 2013. That is supposed to create huge tailwinds throughout the entire video game industry, and those tailwinds should power meaningfully improved results at GameStop.Ahead of this game-changing catalyst, investors and insiders alike are buying GME stock in bulk. In September 2019, five different insiders executed six different open market purchases of GME stock -- the first open market purchases by insiders since September 2016. * 10 Stocks to Buy Regardless of Q3 Earnings The big question now is will the big rebound in GME stock continue? I think so. There's a lot of optimism out there regarding the 2020 video game console upgrade cycle, and all this optimism will continue to translate into strong demand for GME stock. Kraft Heinz (KHC)Source: Casimiro PT / Shutterstock.com A lot has gone wrong for global consumer staples giant Kraft Heinz (NASDAQ:KHC) over the past few years, as an obsession with cost-cutting has come at the expense of growth. But, one thing that has gone right over the past few months is that insiders are finally starting to buy the dip in beaten up KHC stock.Over the past twelve months, KHC stock has dropped 40%. For the first nine months of that selloff, insiders refused to buy the dip. There were zero insider purchases during that stretch. But, over the past three months, insiders have fully embraced a "buy-the-dip" mentality. During this stretch, there have been a whopping 22 insider purchases.This insider vote of confidence has sparked life back into KHC stock. Most of the insider buying started in mid-August. Since then, KHC stock is up 13%.Will this newfound strength in KHC stock persist? It could. There's a new management team here, and this new management team is less obsessed with cutting costs than its predecessors. Instead it's more obsessed with organic growth. That's the right mindset to adopt going forward. It should stabilize revenue growth and return the company to positive profit growth.If that happens, then KHC stock -- which presently trades at just 12.6 times forward earnings -- has plenty of room to run higher.As of this writing, Luke Lango was long ULTA, TJX and GME. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Buy-and-Hold Stocks to Play Investing's Biggest Trends * 7 Stocks to Buy in November * 5 Strong Buy Stocks Under $5 With Massive Upside Potential The post 5 Cheap Stocks Welcoming Insider Buying appeared first on InvestorPlace.
Estée Lauder (EL) reported better-than-expected results for the first quarter of fiscal 2020. However, the stock has fallen 5.2% as of 11:30 AM ET today.
Recently, CNBC reported that Piper Jaffray had downgraded Estée Lauder stock to “neutral” from “overweight.” EL has corrected about 7% so far in October.
Guggenheim says shares of the cosmetics and skin-care retailer have declined too much. On Tuesday, Guggenheim analyst Steven Forbes reiterated a Buy rating on Ulta, although he lowered his price target by $25, to $300. Ulta was up 1.4% to $238.43 in morning trading.
Coty (COTY) gains on advancements in its Luxury business and e-commerce platform. However, sluggishness in the Consumer and Professional Beauty segment is a worry.
Shake Shack, Ulta Beauty, Delta, American and Southwest highlighted as Zacks Bull and Bear of the Day
Low leasing velocity and negative net absorption in the Manhattan office market will likely have negatively impacted SL Green Realty's (SLG) Q3 results.
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don't publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That's why we analyze the […]